Epigenetic regulation of chromatin structure is central to the process of DNA repair. A well-characterized epigenetic feature is the dynamic phosphorylation of the histone H2AX (cH2AX) and mobilization of double strand break (DSB) recognition and repair factors to the site. How chromatin structure is altered in response to DNA damage and how such alterations influence DSB repair mechanisms are currently relevant issues. Despite the clear link between histone deacetylases (HDACs) and radiosensitivity, how histone hyperacetylation influence DSB repair remains poorly understood. We have determined the structure of chromatin is a major factor determining radiosensitivity and repair in human cells. Trichostatin A (TSA) enhances radiosensitivity with dose modification factors of 1.2 and 1.9 at 0.2 and 1 lM, respectively. Cells treated with TSA causing hyperacetylation and remodelling on euchromatic alleles coexist with cH2AX accumulation in radiosensitized cells. Formation of cH2AX on heterochromatin was significantly reduced even when cells were treated with TSA, suggesting that chromatin structure and histone hyperacetylation are pronounced features of radiation sensitivity and repair in euchromatic regions.
Introduction
The key structural element of chromatin is the nucleosome core. The nucleosome unit consists of two molecules of each of the four core histones; H2A, H2B, H3 and H4 wrapped around 146 bp of DNA.
Each histone consists of two domains, a histone fold domain involved in histone-histone interactions and wrapping DNA around nucleosomes and a aminoterminal domain that stretches out the nucleosome core and is involved in interpreting regulatory determinants and DNA. The amino tails are abundant with lysine residues that are targeted for hyperacetylation (El-Osta and Wolffe, 2000) .
Histone deacetylase (HDAC) inhibitors are currently in clinical trials and promising anticancer effects at well-tolerated doses have been observed in phase I and II trials, particularly with cyclic tetrapeptide, depsipeptide (Piekarz et al., 2004) and the hydroxamic acid, suberoylanilide hydroxamic acid (Kelly and Marks, 2005) . The anticancer effects of HDAC inhibitors are caused in part by the accumulation of acetylated histones, which results in altered transcription of a finite number of genes, including various tumour suppressor genes (Marks et al., 2004; Marks and Dokmanovic, 2005) . Additionally, HDAC inhibitors alter gene transcription by modulating the acetylation status of transcription factors or components of the transcriptional machinery (Marks et al., 2004) . Furthermore, they alter the activity of numerous other proteins, including key regulators of signalling cascades such as pRB and p53, which are subject to reversible acetylation on lysine residues (Kelly and Marks, 2005) . The biological effect is induction of differentiation, cell growth and cell-cycle arrest and in certain cases apoptosis in numerous cancer cell-lines. Additionally, HDAC inhibitors have been shown to alter the transcription of critical regulators of invasion and to inhibit angiogenesis in vivo (Kim et al., 2001) .
In addition to possessing intrinsic anticancer activity, HDAC inhibitors are additive or synergistic with conventional cancer therapies such as radiotherapy. Indeed, numerous studies have shown that HDAC inhibitors can enhance the radiation sensitivity of various cancer cell lines in culture and in vivo (Camphausen et al., 2004a (Camphausen et al., , b, 2005 Zhang et al., 2004; Chinnaiyan et al., 2005; Jung et al., 2005; Karagiannis et al., 2005; Munshi et al., 2005) . Mechanisms, including modulation of cell-cycle regulation, particularly G1-phase arrest, inhibition of DNA synthesis and apoptosis, have been identified to explain this effect (Zhang et al., 2004; Karagiannis et al., 2005) . It is well known that the radiosensitivity of cells correlates strongly with cell-cycle distribution (Zhivotovsky et al., 1999) and it is evident that this is an important mechanism underlying radiation sensitization by HDAC inhibitors at relatively high concentrations. Although various studies have established a connection between HDAC inhibition and proteins involved in signal cascades in response to DNA damage, the mechanism by which HDAC inhibitors enhance radiation sensitivity at low concentrations in human cells remain unclear. We previously reported that the inhibition of HDACs enhances the radiation sensitivity and accumulation of the sensitive marker of double strand breaks (DSBs), gH2AX (Karagiannis et al., 2005) . Here, we investigate the effect of trichostatin A (TSA) on radiation-induced DSB repair in transcriptionally active or inactive euchromatin and constitutive heterochromatin analyses of gH2AX accumulation and hyperacetylation of histone H3 using chromatin immunoprecipitation (ChIP). We show that pre-treatment with low concentration of TSA before irradiation, results in classic hallmarks such as histone hyperacetylation and the stable accumulation of gH2AX that is more pronounced in euchromatic alleles than heterochromatic areas of the genome. Our combined results suggest that the inhibition of HDACs can potentiate radiosensitivity by a mechanism that renders DNA more accessible to radiation by histone hyperacetylation in the absence of cytostasis, apoptosis and/ or growth arrest in mammalian cells.
Results
We investigated the effect of a low (0.2 mM) and high (1 mM) concentration of TSA, on the radiosensitivity and on the effect on DSB repair in mammalian cells, using clonogenic survival and gH2AX expression as end points. We compared the effect of TSA on radiationinduced DSB repair in transcriptionally active euchromatin, unexpressed euchromatin and constitutive heterochromatin (Camphausen et al., 2005) . Previously we demonstrated that 24 h incubation with both concentrations of TSA is sufficient to cause accumulation of hyperacetylated nuclear histones (Karagiannis et al., 2005) . Investigation of the effects of treatment of K562 cells with TSA for 24 h indicates that 0.2 mM does not have a significant effect on cell-cycle distribution and apoptosis compared with untreated cells (Figure 1a-c) . In contrast, exposure of K562 cells to 1 mM TSA results in changes in cell-cycle distribution with a predominant sub-G1 peak and in the induction of apoptosis (Figure 1a-c) .
The results from clonogenic survival assays indicated that survival decreased by approximately 5.8 and 64.3% when cells were treated for 24 h with 0.2 and 1 mM TSA, respectively, compared with untreated cells (Figure 1d) . Importantly, the data indicated that TSA sensitized the cells to the effects of g-radiation (Figure 1d) . A radiation dose of 2 Gy was chosen for these experiments, as it reduces survival to approximately 37% (D 37 is defined as the radiation dose required to kill the average cell according to a Poisson distribution). When we normalize the data to take into account the reduction of survival that results from treatment with TSA alone, the dose modification factors (ratio of radiation doses in HDAC inhibitor treated and untreated cells that yield the same cell kill) are calculated to be 1.2 and 1.9 for 0.2 and 1 mM TSA, respectively. It has been postulated that mechanisms, including cell-cycle arrest, inhibition of DNA synthesis and apoptosis (Zhang et al., 2004; Karagiannis et al., 2005) , are at least in part responsible for the radiosensitizing effect of HDAC inhibitors, particularly at the higher inhibitor concentrations. Our findings, which indicate that 1 mM TSA alone alters cellcycle distribution and induces apoptosis, are consistent with this idea.
Phosphorylation of H2AX to form gH2AX occurs rapidly following the induction of DSBs (Rogakou et al., 1998) . It is established that the gH2AX form of the histone has an important role in recruiting repair factors to nuclear foci following induction of DSBs and g-H2AX expression is widely used as a sensitive marker of ionizing radiation-induced DSBs (Foster and Downs, 2005) . Therefore, gH2AX levels have been used to monitor the effect of treating cells with HDAC inhibitors before irradiation on DSB repair. Studies have shown that incubation of cells with HDAC inhibitors, including MS-275 (Camphausen et al., 2004a) , sodium butyrate (Munshi et al., 2005) , valproic acid (Camphausen et al., 2005) and TSA (Karagiannis et al., 2005) before irradiation, results in enhanced expression of radiation-induced gH2AX foci, suggesting a decrease in the repair of DSBs. Although these data point to a role of chromatin in the DNA damage response, it remains unclear to what extent they differ between constitutive heterochromatin and active versus unexpressed euchromatin compartments.
Cells treated with TSA show hyperacetylation of histones H3 and H4 at 0.2 and 1 mM (Figure 2a ). To confirm that TSA hyperacetylates nucleosomal histones, we performed ChIPs against hyperacetylated histones H3 and H4. Cells treated with 0.2 mM TSA show accumulation of H3 and H4 acetylation on euchromatic alleles, however, constitutive heterochromatin loci are resistant to HDAC inhibition (active euchromatin and unexpressed euchromatin representatives are shown in Figure 2b ). These results confirm that euchromatic loci are subject to hyperacetylation of histones by disrupting HDACs. Next, we investigated the chromatin landscape by analysing gH2AX accumulation subject to radiation sensitivity and TSA-induced hyperacetylation of H3 and H4 at six representative regions of the genome ( Figure 2c ). We found that 2 Gy could provoke significant changes in gH2AX on euchromatic foci, suggesting penetrance at these alleles. In marked contrast, heterochromatic sites are highly resistant to DSB and this is clearly illustrated in the gH2AX ChIPs on satellite 2 juxtacentromeric and a-satellite centromeric alleles. Together, these data suggest that euchromatic regions of the genome are more amenable to radiation-induced DNA damage and gH2AX accumulation.
Next, we investigated whether TSA-mediated histone hyperacetylation could provoke and augment gH2AX accumulation subject to radiation sensitivity. Consistent with the idea that histone hyperacetylation can decondense and remodel chromatin structure, cells exposed to 0.2 mM TSA preceding 2 Gy g-radiation caused significant gH2AX concentration (Figure 2d ). We found that upon increased histone acetylation, we could distinguish phosphorylated gH2AX in genes representing active euchromatin (serum albumin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)) and unexpressed euchromatin (alcohol dehydrogenase 5 and b-globin). In comparison, gH2AX accumulation was unremarkable at sites indicative of constitutive heterochromatin (satellite 2 juxtacentromeric) and in accordance with the lack of histone acetylation by TSA at these sites. Cells treated with TSA (0.2 or 1 mM) for 24 h, washed, irradiated with 2 Gy and incubated for a further 2 or 72 h at 371C before analysis by ChIP. We could discern significant changes in the degree of gH2AX accumulation (c) Induction of apoptosis was also investigated by caspase 3-and caspase-7 assay relative fluorescence unit (RFU). Apoptosis in untreated (control) and in K562 cells treated with 50 mM etoposide for 1 h is also shown. Effect of TSA on clonogenic survival and DSB repair of irradiated K562 cells. (d) Cells were treated with 0.2 and 1 mM TSA for 24 h or with a combination of TSA and subsequent irradiation with the 2 Gy g-rays, before cloning.
Trichostatin A suppresses repair in euchromatin TC Karagiannis et al following irradiation at euchromatic and heterochromatic sequences (Figure 2d ). In particular, heterochromatin sites were highly resistant to radiation and TSA treatment; the results of these experiments clearly show that TSA treatment at 0.2 and 1 mM could heighten DNA damage and gH2AX accumulation at 72 h. More notable were the levels of gH2AX enrichment on serum albumin and alcohol dehydrogenase 5 alleles at 2 h. These results indicate a hierarchy in radiosensitivity, namely, chromatin structure and nucleosomal decondensation subject to HDAC inhibition by TSA at low dose (0.2 mM but not 1 mM TSA) can significantly suppress DNA repair in euchromatin generalized by the protracted accumulation of gH2AX.
As the relationship between the level of histone acetylation and the degree of chromatin relaxation are tightly correlated (Reyes et al., 1997) , we tested for structural changes in chromatin decondensation as a result of TSA-induced hyperacetylation. We examined micrococcal S7 nuclease (MNase) sensitivity on serum albumin and satellite 2 chromatin alleles as representatives of euchromatic and heterochromatic sequences. The nuclei of cells in the presence or absence of TSA were subjected to MNase for various times and the purified DNA was analysed for accessibility to ChIPtarget sequences by polymerase chain reaction (PCR) (Figure 3) . The euchromatic serum albumin gene had a significantly higher level of MNase sensitivity than satellite 2 juxtacentromeric chromatin. The euchromatin ChIP target showed a significant difference in MNase digestion patterns from satellite 2 DNA in the presence of the HDAC inhibitor. These results suggest that low doses of TSA at 0.2 mM modify euchromatin structure to a more relaxed state, suggestive of increased accessibility and chromatin decondensation. In contrast, changes in chromatin structure by TSA at satellite 2 heterochromatin were identifiable but less pronounced.
Discussion
Given the growing interest in the potential clinical use of HDAC inhibitors in combination with radiotherapy in cancer patients, it is important to decipher the molecular details of the radiation sensitizing effects of these compounds. Our findings, demonstrate TSA is more efficient in suppressing DSB repair in euchromatic areas, compared with heterochromatic regions of the genome, add to the knowledge regarding the radiation sensitizing properties of HDAC inhibitors. Perhaps, these results demonstrate the applicability of low dose HDAC inhibitors to facilitate radiosensitivity. Mammalian cells are an ideal model system for studying chromatin behaviour and modifications, because the most abundant covalent modification of DNA is the methylation of cytosine residues after chromosomal replication. DNA methylation is associated with chromatin condensation, the formation of specialized nucleosomal structures and inversely linked with transcriptional repression (Kass et al., 1997; El-Osta and Wolffe, 2000) . Repetitive sequences such as satellites also represent a significant segment of the heterochromatic-methylated human genome (Ehrlich, 2002) . By contrast, most mechanistic insights into DNA Figure 2 Disparity of gH2A.X formation on genes corresponding to active euchromatin, inactive euchromatin and heterochromatin regions in response to g-radiation. (a) Cells were treated with TSA (0.2 or 1 mM) and protein extracts prepared after 24 h of exposure, resolved on SDSpolyacrylamide gel electrophoresis (PAGE) and analysed by Western blotting with either a acetyl-H3, a acetyl-H4 or GAPDH (ab9484) antibodies. (b) Cells were treated with TSA for 24 h and analysed by ChIP for hyperacetylated H3 and H4 association on indicative euchromatic and heterochromatic alleles, serum albumin, b-globin and a-satellite, respectively. (c) Cells were treated with TSA for 24 h, washed, irradiated with 2 Gy and incubated for a further 72 h at 371C. Enrichment of gH2A.X was analysed by realtime PCR on active euchromatic genes such as serum albumin and GAPDH, inactive euchromatin include alcohol dehydrogenase 5 and b-globin alleles and inactive heterochromatin represented by satellite 2 juxtacentromeric and a-satellite centromeric sequences. (d) Cells were treated with TSA (0.2 or 1 mM) for 24 h, washed, irradiated with 2 Gy and incubated for a further 2 or 72 h at 371C before analysis. Enrichment of gH2A.X was assayed by ChIP and quantitative real-time PCR and expressed as fold changes in amplification of the þ Ab bound fractions compared with ÀAb and input controls. Representative genes analysed are euchromatic alleles serum albumin and alcohol dehydrogenase 5 and heterochromatin represented by satellite 2 juxtacentromeric sequences.
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Trichostatin A suppresses repair in euchromatin TC Karagiannis et al damage and repair have come from invertebrate studies (Tsukuda et al., 2005; Vidanes et al., 2005) . Although there are striking parallels in the repair machinery between mammalian and other organisms, the yeast genome does not contain any detectable cytosine guanine dinucleotide methylation (Kladde et al., 1996; Xu et al., 1998 ). An indication that chromatin structure and organization can account for the heterogeneity in DNA repair comes from studies examining transcriptionally active genes. Nuclease sensitive regions, such as active promoters are repaired in minutes, whereas the repair on nucleosomes can take as long as several hours (Suter et al., 1997) . Indeed, enhanced repair of active genes is significant and understates the importance of open chromatin structures, which appear to remain accessible during DNA repair (Meier et al., 2002) . Chromatin is in fact a dynamic and heterogenous substrate for DNA repair that is modulated by modifications to the epigenome and other protein/DNA interactions. The efficiency of DNA repair is associated with chromatin structure, nucleosome accessibility/disruption and transcriptional activity (Thoma, 1999; Orphanides and Reinberg, 2000) . Euchromatic alleles examined in this study show responsive histone H3 and H4 hyperacetylation with low dose TSA. We predict changes in nucleosome accessibility are consequential to increased H2A.X association and the more open euchromatin environment. Chromatin immunoprecipitation experiments indicate heterogeneity of damage formation and repair attributed in part to the dynamic properties and behaviour of nucleosomal DNA (Taddei et al., 1999 (Taddei et al., , 2001 ). In other words, not all chromatin should be considered equivalent in structure/function, including damage recognition/repair and this is reflected in our experiments examining phosphorylation of H2A.X at distinct regions of the genome. In particular, detection of gH2A.X was significantly lower on heterochromatic satellite 2 sequences and a-satellite repeats suggestive of reduced radiosensitivity, damage recognition or delayed DNA repair (Terleth et al., 1990; Livingstone-Zatchej et al., 2003) . We can begin to interpret these results in the context of chromatin as a substrate for repair. Drawing on our understanding and composition of the heterochromatin environment might help to explain these results, which is interrelated with repressive chromatin structures, histone modifications and genomic methylation that are associated with transcriptional silencing. This raises several intriguing questions of whether stochastic and reversible gene silencing can modulate damage recognition and DNA repair. Experimental studies suggest that transcriptionally active chromatin is more efficiently repaired after ultraviolet and ionizing radiation exposure (Chiu et al., 1982; Mellon et al., 1986) . Phosphorylation of H2A.X is a rapid and extensive response to the formation of doublestrand DNA breaks. Ionizing radiation-induced DNA damage stimulates H2A.X phosphorylation, however, TSA does not appear to generate significant levels of the phosphorylated histone variant. We hypothesize that increased levels of gH2AX detected at 72 h are associated with suppression of DNA repair, however, these changes could also reflect altered molecular pathways associated with differences in initial DNA damage events. In our study, we establish an asymmetric response to DNA damage and gH2AX accumulation at heterochromatin sites. Rational drug design has been proposed previously as means of creating HDAC inhibitors that are optimized for their radiosensitizing qualities. In this context, the radiation-sensitizing efficacy may be improved by developing inhibitors that sensitize both euchromatic and heterochromatic compartments. This represents a formidable but fascinating challenge, and given the renewed interest and applicability of the DNA methylation inhibitors (Baylin, 2005; Lyko and Brown, 2005) in the treatment of epigenetic diseases it also provides an intriguing opportunity.
Materials and Methods
Cell culture, treatment with TSA and g-irradiation Human chronic myelogenous leukaemia K562 cells were grown as described (Karagiannis et al., 2005) . K562 cells (10 6 /ml) in complete Rosewell Park Memorial Institute-1640 medium were treated with 0, 0.2 and 1 mM TSA (Sigma Chemical Co. Ltd., St Louis, MO, USA), for 24 h at 371C. Following incubation, cells were washed twice by centrifugation at 700 g for 5 min. Subsequently, cells were either examined for cell-cycle distribution, clonogenic survival and apoptosis using methods described below, or were subjected to further treatment before analysis. Untreated K562 cells and cells that had been pre-treated with TSA were exposed to 2 Gy g-radiation from a 137 Cs source at a dose rate of approximately 0.7 Gy/min (Karagiannis et al., 2005) .
Flow cytometry, caspase activity and clonogenic survival assays The cell-cycle distribution of K562 cells was monitored by flow cytometry as described previously (Karagiannis et al., 2005) . Induction of apoptosis was examined by measuring the activities of caspase-3 and caspase-7, using the apo-ONE homogeneous caspase-3/7 assay (Promega, Madison, WI, USA) according to the manufacturer's instructions. The effects of TSA treatment and of combinations of TSA pretreatment and g-radiation on cell death were examined by cloning in semi-solid (0.33%) agar as described elsewhere (Karagiannis et al., 2005) .
Chromatin fractionation and MNase nuclease accessibility Isolation of chromatin was performed essentially as described by Reyes et al. (1997) with some modifications. Cells (1 Â 10 6 ) were harvested, washed twice in ice-cold phosphate-buffered saline and resuspended in 0.2 ml of nuclear buffer (20 mM TrisHCl, pH 7.5, 70 mM NaCl, 20 mM KCl, 5 mM MgCl 2 , 3 mM CaCl 2 and protease inhibitor cocktail). Soluble nuclei were resuspended with 200 U micrococcal (S7) nuclease (Worthington Biochemical Corp., Lakewood, NJ, USA). The digestion reaction was terminated at indicated lengths of time with 5 mM ethylenediaminetetraacetic acid (EDTA) and ethyleneglycol tetraacetate at room temperature. DNA was isolated using Zymogen DNA extraction kit, purified by phenol:-chloroform extraction and analysed using PCR. Nuclear accessibility was assessed by linear phase amplification of sequences corresponding to human serum albumin (Accession Figure 3 Euchromatin is actively remodelled by HDAC inhibition and more amenable to micrococcal S7 nuclease cleavage than heterochromatin. Cells were incubated in the absence or presence of TSA and digested with MNase in nuclear buffer for increasing times, as indicated. Purified genomic DNA was subjected to PCR amplification of the representative euchromatin and heterochromatin sequences, serum albumin and satellite 2 juxtacentromeric, respectively. Samples were size fractionated by PAGE and stained with ethidium bromide for visualization.
Trichostatin A suppresses repair in euchromatin TC Karagiannis et al number M12523), b-globin (U01317) and a-satellite (M38467) (Jiang et al., 2004) . Sequences are available upon request. The PCR consisted of 1 Â PCR buffer and 1.5 mM MgCl 2 , 200mM of each deoxynucleoside triphosphate, 100 pmol forward and reverse primers and 1 U of HotStarTaq/reaction. The initial activation step was 951C for 15 min, followed by 30-40 cycles of denaturation at 941C for 60 s, annealing at 501C for 60 s and extension at 721C for 60 s and a final extension at 721C for 10 min. We size fractionated the samples by polyacrylamide gel electrophoresis and stained by ethidium bromide. Images were captured using Quantity One imaging and analysis software (Bio-Rad, Hercules, CA, USA).
Soluble ChIP assays K562 cells were treated with formaldehyde at a final concentration of 1% for 10 min at room temperature and the ChIP assay performed as described previously (Harikrishnan et al., 2005; Karagiannis et al., 2005) . Chromatin samples were precleared with protein A/G agarose beads (Santa Cruz, Santa Cruz, CA, USA) before immunoprecipitation against hyperacetylated histones a-H3 (Upstate Biotech, Millipore, Billerica, MA, USA, 06-599) and a-H4 (Upstate Biotech, 08-666) or a-Histone H2A.X phosphorylated at Ser139 polyclonal antibody (Upstate Biotech, 07-164) overnight at 41C. Immune complexes were collected with protein A/G agarose beads, washed and samples eluted twice with 1% sodium dodecyl sulphate (SDS), 0.1 M NaHCO 3 for 10 min at room temperature. Eluates were combined and NaCl added at a final concentration of 100 mM and heated overnight at 651C to reverse crosslinks. DNA was recovered by phenol/chloroform extraction, precipitated by ethanol and resuspended in Tris-EDTA buffer solution pH 7.4. Resuspended DNA was amplified by PCR with oligonucleotide sequences corresponding to human GAPDH gene (J04038), alcohol dehydrogenase 5 gene (ADH5, U10902), serum albumin (M12523), b-globin (U01317), satellite 2 (X72623) and a-satellite (M38467) (Jiang et al., 2004) . Sequences are available upon request. We performed PCR amplification in 96-well plates using 20 pmol of forward and reverse primers, 1 Â Platinum SYBR Green qPCR SuperMix-UDG and Rox Reference Dye (Invitrogen, Carlsbad, CA, USA) 2 min at 501C and then for 10 min at 951C followed by 40-50 cycles of 951C for 15 s and 561C for 60 s (Applied Biosystems, Foster City, CA, USA). Fold changes were calculated in the following manner; the cycle number (Ct) of the target genes were extrapolated from the software analysis program (SDS 1.9, Applied Biosystems) and was subtracted from the Ct of the input control and this difference in Ct is known as the DCt. All means, standard error of means and statistics were calculated as a fold value (Harikrishnan et al., 2005; Karagiannis et al., 2005) . We also performed control ChIPs to test specificity of gH2A.X antibody binding with a no antibody control. Quantitative values are expressed as a ratio of the þ Ab bound subtracted from the ÀAb control and normalized against the input control as a reference. Values for gH2A.X enrichment are expressed as a fold change relative to the mean control value.
